A Study of LY2405319 in Participants With Type 2 Diabetes

Summary

The main purpose of this study was to evaluate the safety and tolerability of LY2405319. It was given as a daily injection under the skin to participants with type 2 diabetes mellitus (T2DM) for 28 days. This study determined how long the drug stays in the body and how it affects blood sugar levels. After screening, the study lasted about 2 months for each participant. Participants continued their prestudy regimen of diet and exercise alone or in combination with metformin.

Timeline

Start

2009-04

Primary completion

2009-06

Completion

2009-12

Drugs

Indications